Invitae Appoints Dr. W. Michael Korn as Chief Medical Officer for Oncology

– Expert in the field of gastrointestinal cancer and precision oncology to lead Invitae's medical oncology team with a particular focus on somatic testing development – – Invitae reports inducement grant under NYSE Rule 303A.08 – SAN FRANCISCO, March 16, 2023 /PRNewswire/ -- Invitae...

Click to view original post